Vertex Pharmaceuticals Stock a Buy on Any Pullback Hosted by Laycee KluinNovember 16, 2023Add As Preferred SourceShareShareShare This VideoLink copied to clipboard. Play video for Vertex Pharmaceuticals Stock a Buy on Any PullbackDetailsGuestsShares of Vertex Pharmaceuticals stock are down nearly 2% after the company delivered its third-quarter earnings report. The news wasn't particularly bad, although there was a slight miss on the top line. But with VRTX stock up over 30% in 2023, it's fair to say that the stock was priced for perfection. A miss, no matter how small, is not the perfection that investors are looking for. However, this is creating a pullback that may be a buying opportunity.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioVRTXVertex Pharmaceuticals3.5125 of 5 stars$526.19+0.7%N/A30.63 Add This Stock to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatPrevious VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube Listen to MarketBeat Other Platforms Recent VideosApple and Meta Just Dropped New Tech (3 Stocks Most Investors Are Missing)MarketBeat TV | September 24, 2026Watch VideoTrump Is Betting Billions on These Stocks (You'll Regret Following)MarketBeat TV | September 23, 2026Watch VideoThese Stocks Almost Died... Now They're Up 130% (UNTHINKABLE Comeback)MarketBeat TV | September 22, 2026Watch Video Featured Articles and OffersNVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In ItSeptember 20, 2026This AI Stock Reminds One Analyst of Early NvidiaFrom Brownstone Research (Ad)Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?September 21, 2026The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing InSeptember 20, 2026Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of RisksSeptember 24, 20266 Elon Musk companies. The 1 FREE investor roadmap to them all.From Zacks (Ad) Search Headlines Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinNovember 16, 2023Add As Preferred SourceShareShareShare This VideoLink copied to clipboard. Play video for Vertex Pharmaceuticals Stock a Buy on Any PullbackDetailsGuestsShares of Vertex Pharmaceuticals stock are down nearly 2% after the company delivered its third-quarter earnings report. The news wasn't particularly bad, although there was a slight miss on the top line. But with VRTX stock up over 30% in 2023, it's fair to say that the stock was priced for perfection. A miss, no matter how small, is not the perfection that investors are looking for. However, this is creating a pullback that may be a buying opportunity.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioVRTXVertex Pharmaceuticals3.5125 of 5 stars$526.19+0.7%N/A30.63 Add This Stock to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatPrevious VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube
